The data from genetic tests confirm that among five RCM patients, two patients carry 192 point mutation in cTnI gene and two carry a point mutation in myosin gene, and one patient with no detectable myofibril protein mutation. Here, TNNI3 is linked to cardiomyopathy, familial restrictive, 1.